(c) Four weeks after intervention
| Markers | ESWT group | Sham group | p value |
|---|---|---|---|
| IL-6 | 1.97 (1.23, 2.73) | 1.69 (1.26, 2.11) | 0.263 |
| TNF-α | 0.92 (0.70, 1.41) | 0.74 (0.48, 1.18) | 0.111 |
| IL-1β | 3.24 (1.42, 4.79) | 1.62 (0.74, 3.39) | 0.255 |
| TGF-β1 | 22739.9 (16866.4, 30116.9) | 22333.6 (19238.3, 25252.1) | 0.568 |
| VEFG | 177.68 (107.51, 203.46) | 159.75 (72.13, 221.06) | 0.947 |
| Sub P | 182.28 (160.39, 223.34) | 193.86 (130.87, 320.81) | 0.681 |
| DKK-1 | 3449.47 (2915.13, 3825.28) | 3281.84 (3008.54, 3939.20) | 0.535 |
| IGF-1 | 132.18 (105.82, 147.21) | 138.80 (113.45, 148.44) | 0.533 |
DKK-1: dickkopf-related protein 1; IGF-1: insulin-like growth factor-1; IL-1β: interleukin 1-beta; IL-6: interleukin 6; Sub P: substance P; TGF-β1: transforming growth factor-beta 1; TNF-α: tumor necrosis factor-alpha.